We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $22.7B
This Fund
S&P 500
This Quarter Est. Return
+18.69%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.7B
AUM Growth
+$2.27B
Cap. Flow
-$358M
Cap. Flow %
-1.58%
Top 10 Hldgs %
27.07%
Holding
1,590
New
113
Increased
536
Reduced
704
Closed
103

Top Sells

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$205M
2
PANW icon
Palo Alto Networks
PANW
+$43.8M
3
HON icon
Honeywell
HON
+$41.6M
4
MRVL icon
Marvell Technology
MRVL
+$39.1M
5
ORCL icon
Oracle
ORCL
+$26.3M

Sector Composition

Rank Sector Weight
1 Miscellaneous 29.48%
2 Technology 23.07%
3 Financials 9.4%
4 Healthcare 8.74%
5 Consumer Discretionary 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORI icon
901
Old Republic International
ORI
$9.86B
$646K ﹤0.01%
15,784
-15,694
-50% -$622K
VSAT icon
902
Viasat
VSAT
$9.97B
$645K ﹤0.01%
+7,183
New +$476K
VGK icon
903
Vanguard FTSE Europe ETF
VGK
$30.6B
$643K ﹤0.01%
7,267
RY icon
904
Royal Bank of Canada
RY
$286B
$642K ﹤0.01%
3,101
+618
+25% +$115K
EXPD icon
905
Expeditors International
EXPD
$24.5B
$639K ﹤0.01%
3,921
-72,666
-95% -$11.2M
MLPB icon
906
ETRACS Alerian MLP Infrastructure Index ETN Series B due Apr 2 2040
MLPB
$261M
$635K ﹤0.01%
+22,045
New +$639K
AVT icon
907
Avnet
AVT
$7.53B
$634K ﹤0.01%
7,134
-933
-12% -$76.3K
URGN icon
908
UroGen Pharma
URGN
$2.2B
$633K ﹤0.01%
17,206
+6,689
+64% +$181K
FSS icon
909
Federal Signal
FSS
$7.17B
$632K ﹤0.01%
4,918
-1,615
-25% -$185K
KEX icon
910
Kirby Corp
KEX
$7.32B
$620K ﹤0.01%
4,562
-461
-9% -$65.9K
OXY icon
911
Occidental Petroleum
OXY
$61.3B
$617K ﹤0.01%
12,699
-39,114
-75% -$2.22M
SRRK icon
912
Scholar Rock
SRRK
$6.65B
$616K ﹤0.01%
11,205
+960
+9% +$46.4K
CRL icon
913
Charles River Laboratories
CRL
$13.3B
$616K ﹤0.01%
2,714
+8
+0.3% +$1.43K
GPC icon
914
Genuine Parts
GPC
$18.6B
$615K ﹤0.01%
5,210
-1,572
-23% -$164K
ESS icon
915
Essex Property Trust
ESS
$17.6B
$614K ﹤0.01%
2,104
+87
+4% +$23.4K
CYTK icon
916
Cytokinetics
CYTK
$10.3B
$613K ﹤0.01%
7,191
+528
+8% +$37.9K
UMC icon
917
United Microelectronic
UMC
$56.9B
$612K ﹤0.01%
22,494
-4,496
-17% -$76.8K
SCHD icon
918
Schwab US Dividend Equity ETF
SCHD
$110B
$609K ﹤0.01%
19,219
-2,197
-10% -$69.7K
EEMV icon
919
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.67B
$608K ﹤0.01%
8,076
-1,790
-18% -$129K
MGM icon
920
MGM Resorts International
MGM
$10.2B
$604K ﹤0.01%
12,641
-49
-0.4% -$2.04K
VSS icon
921
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12B
$600K ﹤0.01%
3,886
-100
-3% -$15.7K
SMTC icon
922
Semtech
SMTC
$15.3B
$598K ﹤0.01%
3,693
-14,739
-80% -$1.93M
E icon
923
ENI
E
$80.7B
$594K ﹤0.01%
12,676
-817
-6% -$43.8K
STZ icon
924
Constellation Brands
STZ
$20.8B
$594K ﹤0.01%
4,269
-260
-6% -$38.6K
HLN icon
925
Haleon
HLN
$40.6B
$594K ﹤0.01%
63,613
-6,534
-9% -$60.7K

Similar funds

Glenmede Trust's Q2 2026 Portfolio in Review

As of Q2 2026, Glenmede Trust held 1,590 positions worth $22.7B, up 11% from $20.4B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Glenmede Trust's Q2 2026 filing shows 113 new, 536 increased, 704 reduced and 103 closed positions. Its largest new stake was Honeywell Aerospace: 175,141 shares worth $38.7M. The largest sale was RTX Corp, an estimated $205M.

By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 28% a quarter earlier, followed by Technology and Financials.

  • Glenmede Trust's largest Q2 2026 buy was Honeywell Aerospace: 175,141 shares worth $38.7M.
  • Glenmede Trust added most to iShares Core MSCI International Developed Markets ETF in Q2 2026, an estimated $142M increase.
  • Glenmede Trust's biggest Q2 2026 reduction was Palo Alto Networks, cutting an estimated $43.8M.
  • Glenmede Trust fully exited RTX Corp in Q2 2026, selling an estimated $205M.
  • Glenmede Trust's ten largest holdings make up 27% of its $22.7B portfolio in Q2 2026.
  • Glenmede Trust opened 113 new positions and closed 103 in Q2 2026.
  • Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $22.7B.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.